EUCTR2010-020902-13-AT进行中（未招募）1 期
Intravitreal Lucentis (Ranibizumab) in acute central serous Chrioretinopathy - a prospective, randomized, single blind monocentric study
niversitätsklinik für Augenheilkunde und Optometrie, Medizinische Universität Innsbruck0 个研究点目标入组 30 人开始时间: 2011年5月18日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Patient age >18 a, <60 a
- •Diagnosis of CSC by optical coherence tomography and fluorenscence angiography
- •Symptom duration less than three months
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Present ocular, intraocular, or periocular infection
- •Recurrent CSC
- •St.p. intraocular surgery within the past year
- •St.p. Argon laser coagulation of the retina
- •St.p. Photodynamic therapy
研究者
相似试验
进行中（未招募）
不适用
Injection of Lucentis (Ranibizumab) in the vitreous body of the eye after eye surgery and application of recombinant tissue plasminogen activator (rtPA) in patients with submacular bleeding complications suffering from wet age-related macular degeneration (AMD).exsudative age-related macular degeneration with acut submacular hemorrhageMedDRA version: 16.1Level: LLTClassification code 10055305Term: Macula lutea hemorrhageSystem Organ Class: 100000004853MedDRA version: 16.1Level: LLTClassification code 10067791Term: Wet macular degenerationSystem Organ Class: 100000004853EUCTR2010-018637-21-DEniversitätsklinikum Schleswig-Holstein UKSH
招募中
2 期
Intravitreal Injection of Lucentis (Ranibizumab) after Pars Plana Vitrectomy and Subretinal Application of Recombinant Tissue Plasminogen Activator (rtPA) in Patients with Acute Submacular Hemorrhage as Complication of Exsudative Age-related Macular Degeneration (AMD).exsudative age-related macular degeneration with acut submacular hemorrhageH35.3H35.6Degeneration of macula and posterior poleRetinal haemorrhageDRKS00005090niversitätsklinikum Schleswig-Holstein Campus Kiel15
进行中（未招募）
1 期
Injections into the eye (drug Lucentis) in diabetic patients in whom no further treatment is currently available in clinic when they have developed swelling of the centre of the macula associated with lack of blood supply.Ischaemic Diabetic Macular OedemaMedDRA version: 14.1Level: LLTClassification code 10057915Term: Diabetic macular oedemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012689Term: Diabetic retinopathySystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012688Term: Diabetic retinal oedemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10054372Term: Diabetic retinal edemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10054109Term: Non-proliferative diabetic retinopathySystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012661Term: Diabetic eye diseaseSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10038925Term: Retinopathy diabeticSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: HLGTClassification code 10012653Term: Diabetic complicationsSystem Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.1Level: HLTClassification code 10012657Term: Diabetic complications ophthalmicSystem Organ Class: 10014698 - Endocrine disordersEUCTR2013-000031-27-GBMoorfields Eye Hospital80
已完成
3 期
Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO)Macular EdemaRetinal Vein OcclusionNCT00942864Novartis Korea Ltd.40
已完成
不适用
Intravitreal bevacizumab treatment for severe retinopathy of prematuritysevere retinopathy of prematurityJPRN-UMIN000018122The Jikei University School of Medicine Department of Ophthalmology6